Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
País como asunto
Tipo del documento
Publication year range
1.
J Clin Pharm Ther ; 36(1): 64-70, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21198721

RESUMEN

WHAT IS KNOWN AND OBJECTIVE: There is wide inter-patient and intra-patient variability in the pharmacodynamic profile of warfarin. To determine the prevailing aetiologies of non-therapeutic warfarin anticoagulation episodes among patients currently enrolled in an outpatient anticoagulation clinic and compare the relative frequency in which they occur compared to therapeutic anticoagulation regimens. METHODS: Prospective, observational cohort study set within three pharmacist-managed anticoagulation clinics in a community outpatient health system. Patients were included, if they were seen for an office visit during the 6-month period from September 2006 to March 2007 and evaluated for the presence or absence of 12 investigational factors linked to non-therapeutic anticoagulation results. Multivariate stepwise logistic regression performed to assess predictive value of each factor. RESULTS: A total of 5817 patient-visits were documented producing 2886 (49.6%) non-therapeutic and 2931 (50.4%) therapeutic International Normalized Ratio (INR) readings. The most prevalent aetiologies linked to non-therapeutic INR results included change in dietary vitamin K intake (16.9%, OR 6.4), non-compliance (15.0%, OR 4.9), and initiation of anticoagulant therapy (9.9%, OR 2.3). The factor with the highest predictive value of non-therapeutic INR results was a change in health status (OR 9.5) despite its lower rate of frequency (4.9%). Despite identification of many causative factors in this study, 40.2% of non-therapeutic INR readings had no known aetiology. In the end, the lack of any study factor was a greater predictor of therapeutic anticoagulation (86.2%), than the presence of a study factor was for predicting non-therapeutic INR values (51.4%). WHAT IS NEW AND CONCLUSION: Change in health status was the strongest predictor of non-therapeutic INR levels out of the investigational factors evaluated. Our study demonstrated that there are many aetiologies for non-therapeutic INR values that were not explained by our investigational factors.


Asunto(s)
Anticoagulantes/efectos adversos , Hemorragia/etiología , Warfarina/efectos adversos , Anciano , Instituciones de Atención Ambulatoria , Anticoagulantes/administración & dosificación , Chicago , Estudios de Cohortes , Redes Comunitarias , Dieta/efectos adversos , Monitoreo de Drogas , Femenino , Estado de Salud , Hemorragia/inducido químicamente , Hemorragia/prevención & control , Humanos , Relación Normalizada Internacional/estadística & datos numéricos , Modelos Logísticos , Masculino , Cumplimiento de la Medicación , Actividad Motora , Farmacéuticos , Vitamina K/administración & dosificación , Vitamina K/antagonistas & inhibidores , Warfarina/administración & dosificación
2.
J Fish Dis ; 32(5): 457-63, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-19364387

RESUMEN

Asian sea bass, Lates calcarifer (Bloch), exhibited strong immune responses against a single injection of the formalin-inactivated red-spotted grouper nervous necrosis virus (RGNNV), a betanodavirus originally isolated in Japan. Fish produced neutralizing antibodies at high titre levels from days 10 (mean titre 1:480) to 116 (1:1280), with the highest titre at day 60 post-vaccination (1:4480). When fish were challenged with the homologous RGNNV at day 54 post-vaccination, there were no mortalities in both the vaccinated and unvaccinated control fish. However, a rapid clearance of the virus was observed in the brains and kidneys of vaccinated fish, followed by a significant increase in neutralizing-antibody titres. Furthermore, the vaccine-induced antibodies potently neutralized Philippine betanodavirus isolates (RGNNV) in a cross-neutralization assay. The present results indicate the potential of the formalin-inactivated RGNNV vaccine against viral nervous necrosis (VNN) of Asian seabass.


Asunto(s)
Lubina/inmunología , Nodaviridae/inmunología , Vacunas Virales/inmunología , Animales , Anticuerpos Antivirales/sangre , Pruebas de Neutralización , Vacunas de Productos Inactivados/inmunología
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda